Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
response to thiopurine	EFO_0006317	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of treatment with thiopurine]
tyrosine-protein kinase ABL1 measurement	EFO_0020818	[The determination of the amount of tyrosine-protein kinase ABL1 in a sample]
thiopurine methyltransferase activity measurement	EFO_0007852	[quantification of the activity of the enzyme thiopurine methyltransferase in a sample]
tyrosine-protein kinase BTK measurement	EFO_0020819	[The determination of the amount of tyrosine-protein kinase BTK in a sample]
seroconversion	EFO_0007851	[Seroconversion is the process during which a specific antibody develops and becomes detectable in the blood. During infection or immunisation, antigenes enter the blood and the immune system begins to produce antibodies in response. Before seroconversion, the antigen itself may or may not be detectable but the antibody is, by definition, absent. During seroconversion, the antibody is present but not yet detectable. After seroconversion has occurred, the antibodies can be detected, indicating prior or current infection.]
solar lentigines measurement	EFO_0007850	[quantification of the amount or severity of solar lentigines, flat tan to brown spots sometimes called liver spots, on an individual's skin. Lentigines are associated with skin aging and sun exposure]
tumor necrosis factor receptor superfamily member 3 measurement	EFO_0020813	[The determination of the amount of tumor necrosis factor receptor superfamily member 3 in a sample]
facial depth measurement	EFO_0007857	[quantification of some aspect of facial depth, such as the distance from the tip of the nose to the tip of the ear lobe]
tumor necrosis factor receptor superfamily member 4 measurement	EFO_0020814	[The determination of the amount of tumor necrosis factor receptor superfamily member 4 in a sample]
facial height measurement	EFO_0007856	[quantification of some aspect of facial height, such a the height of the entire face or the height of the upper half of the face]
tumor necrosis factor receptor superfamily member 6B measurement	EFO_0020815	[The determination of the amount of tumor necrosis factor receptor superfamily member 6B in a sample]
facial width measurement	EFO_0007855	[quantification of some aspect of facial width, such a the cranial base width]
tumor necrosis factor receptor superfamily member 8 measurement	EFO_0020816	[The determination of the amount of tumor necrosis factor receptor superfamily member 8 in a sample]
knee peak torque measurement	EFO_0007854	[quantification of peak torque values of the knee flexor muscles]
tumor necrosis factor receptor superfamily member 21 measurement	EFO_0020810	[The determination of the amount of tumor necrosis factor receptor superfamily member 21 in a sample]
tumor necrosis factor receptor superfamily member 25 measurement	EFO_0020811	[The determination of the amount of tumor necrosis factor receptor superfamily member 25 in a sample]
tumor necrosis factor receptor superfamily member 27 measurement	EFO_0020812	[The determination of the amount of tumor necrosis factor receptor superfamily member 27 in a sample]
eye morphology measurement	EFO_0007858	[quantification of some aspect of eye morphology, such as the width of the eye socket]
vitamin k-dependent protein S measurement	EFO_0020850	[The determination of the amount of vitamin k-dependent protein S in a sample]
vps10 domain-containing receptor sorcs2 measurement	EFO_0020851	[The determination of the amount of vps10 domain-containing receptor sorcs2 in a sample]